Pfizer is experiencing the most aggressive sell-off in its history and technicals are aligning for a possible reversal. The stock has given back all of its COVID-19-induced gains and probably giving us a first entry opportunity.
Trade active:
Pfizer stocks plunged after they gave a gloomy expectation for 2024. The news has already been priced in. Reloading on Pfizer today. It is in our desired price.
Comment:
We closed our first Pfizer position at a slight entry and our second position which we entered at $26.26 is still running.